Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Discover effective ways to increase your investment portfolio performance. Enhance your returns and achieve your financial goals.
23,604 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
In February, Newmont Mining surged as gold prices strengthened and earnings topped expectations. This piece breaks do...
Jim Cramer’s blunt message for 2026 is clear: if you only tech stocks, you’re taking on unnecessary risk. This articl...
From repeated loan denials to a growing 10+ unit multifamily portfolio, this deal diary-style story reveals the strat...
The SPDR S&P Retail ETF has posted double-digit gains over the last year, yet leaders emerge among value-focused reta...
Delta leads in profitability amid a volatile fuel backdrop, while JetBlue shows resilience with a tighter balance she...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
As AI hardware demand strengthens, the buy everything ai strategy draws renewed attention. AIQ has posted double-digi...
A new study shows a widening gap between the skills-based hiring mantra and its execution, as more than half of emplo...
The NEOS QQQI ETF offers a high monthly yield, but hidden costs could erode capital in calmer markets. This report ex...
Broadcom is set to report Q1 FY2026 after the close as investors weigh AI-driven demand and margins. This live earnin...
Elon Musk’s wealth narrowed dramatically after SpaceX’s IPO, underscoring how quickly fortunes hinge on a single comp...